Novo Nordisk

Switching to Ozempic® from another GLP-1 RA significantly reduced blood sugar and weight in people with type 2 diabetes in routine clinical practice

BAGSVÆRD, Denmark, June 13, 2020 ­/PRNewswire/ — Novo Nordisk today announced results from two real-world studies: EXPERT, which confirms the…